Does the media refer more to HIT or OPRX?

In the previous week, OptimizeRx had 1 more articles in the media than Health In Tech. MarketBeat recorded 3 mentions for OptimizeRx and 2 mentions for Health In Tech. OptimizeRx's average media sentiment score of 1.51 beat Health In Tech's score of 1.12 indicating that OptimizeRx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health In Tech 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OptimizeRx 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media refer more to HCAT or HIT?

In the previous week, Health Catalyst and Health Catalyst both had 2 articles in the media. Health Catalyst's average media sentiment score of 1.82 beat Health In Tech's score of 1.12 indicating that Health Catalyst is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health Catalyst 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Health In Tech 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, HIT or CCLD?

CareCloud has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Health In Tech $32.83M 1.96 -$4.59M -$0.07 N/A CareCloud $120.50M 0.88 $10.80M $0.07 35.57

Does the media prefer HIT or CCLD?

In the previous week, Health In Tech and Health In Tech both had 2 articles in the media. Health In Tech's average media sentiment score of 1.12 beat CareCloud's score of 0.96 indicating that Health In Tech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health In Tech 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CareCloud 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to HIT or DH?

In the previous week, Definitive Healthcare had 1 more articles in the media than Health In Tech. MarketBeat recorded 3 mentions for Definitive Healthcare and 2 mentions for Health In Tech. Health In Tech's average media sentiment score of 1.12 beat Definitive Healthcare's score of 0.83 indicating that Health In Tech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health In Tech 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Definitive Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Health In Tech (HIT) Competitors

$0.98 -0.02 (-2.02%)

As of 08/28/2026 03:59 PM Eastern

Compare

HIT vs. AMWL, OPRX, HCAT, CCLD, and DH

Should you buy Health In Tech stock or one of its competitors? Health In Tech's main competitors and comparable companies include American Well (AMWL), OptimizeRx (OPRX), Health Catalyst (HCAT), CareCloud (CCLD), and Definitive Healthcare (DH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Health In Tech compare to American Well?

Health In Tech (NASDAQ:HIT) and American Well (NYSE:AMWL) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends and valuation.

56.0% of American Well shares are held by institutional investors. 77.7% of Health In Tech shares are held by company insiders. Comparatively, 12.8% of American Well shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Health In Tech has higher earnings, but lower revenue than American Well. Health In Tech is trading at a lower price-to-earnings ratio than American Well, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$32.83M	1.96	-$4.59M	-$0.07	N/A
American Well	$218.53M	0.90	-$95.70M	-$4.77	N/A

In the previous week, Health In Tech had 2 more articles in the media than American Well. MarketBeat recorded 2 mentions for Health In Tech and 0 mentions for American Well. Health In Tech's average media sentiment score of 1.12 beat American Well's score of 0.81 indicating that Health In Tech is being referred to more favorably in the media.

Company	Overall Sentiment
Health In Tech	Positive
American Well	Positive

Health In Tech has a beta of 2.82, suggesting that its stock price is 182% more volatile than the broader market. Comparatively, American Well has a beta of 1.68, suggesting that its stock price is 68% more volatile than the broader market.

Health In Tech currently has a consensus target price of $3.50, indicating a potential upside of 257.14%. American Well has a consensus target price of $9.50, indicating a potential downside of 20.24%. Given Health In Tech's stronger consensus rating and higher possible upside, analysts plainly believe Health In Tech is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Health In Tech has a net margin of 0.00% compared to American Well's net margin of -35.75%. Health In Tech's return on equity of 0.00% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
American Well	-35.75%	-30.12%	-22.30%

Summary

Health In Tech beats American Well on 13 of the 16 factors compared between the two stocks.

How does Health In Tech compare to OptimizeRx?

Health In Tech (NASDAQ:HIT) and OptimizeRx (NASDAQ:OPRX) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, media sentiment, dividends, risk and analyst recommendations.

76.5% of OptimizeRx shares are held by institutional investors. 77.7% of Health In Tech shares are held by company insiders. Comparatively, 7.5% of OptimizeRx shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Health In Tech presently has a consensus price target of $3.50, suggesting a potential upside of 257.14%. OptimizeRx has a consensus price target of $11.43, suggesting a potential upside of 43.76%. Given Health In Tech's stronger consensus rating and higher possible upside, analysts plainly believe Health In Tech is more favorable than OptimizeRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

Health In Tech has a beta of 2.82, indicating that its share price is 182% more volatile than the broader market. Comparatively, OptimizeRx has a beta of 1.08, indicating that its share price is 8% more volatile than the broader market.

In the previous week, OptimizeRx had 1 more articles in the media than Health In Tech. MarketBeat recorded 3 mentions for OptimizeRx and 2 mentions for Health In Tech. OptimizeRx's average media sentiment score of 1.51 beat Health In Tech's score of 1.12 indicating that OptimizeRx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health In Tech	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OptimizeRx	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

OptimizeRx has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$32.83M	1.96	-$4.59M	-$0.07	N/A
OptimizeRx	$98.65M	1.52	$5.13M	$0.23	34.57

OptimizeRx has a net margin of 4.66% compared to Health In Tech's net margin of 0.00%. OptimizeRx's return on equity of 9.44% beat Health In Tech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
OptimizeRx	4.66%	9.44%	7.11%

Summary

OptimizeRx beats Health In Tech on 11 of the 17 factors compared between the two stocks.

How does Health In Tech compare to Health Catalyst?

Health Catalyst (NASDAQ:HCAT) and Health In Tech (NASDAQ:HIT) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

Health Catalyst presently has a consensus price target of $2.45, indicating a potential upside of 54.09%. Health In Tech has a consensus price target of $3.50, indicating a potential upside of 257.14%. Given Health In Tech's stronger consensus rating and higher probable upside, analysts plainly believe Health In Tech is more favorable than Health Catalyst.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.17
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

In the previous week, Health Catalyst and Health Catalyst both had 2 articles in the media. Health Catalyst's average media sentiment score of 1.82 beat Health In Tech's score of 1.12 indicating that Health Catalyst is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health Catalyst	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Health In Tech	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Health Catalyst has a beta of 1.55, suggesting that its stock price is 55% more volatile than the broader market. Comparatively, Health In Tech has a beta of 2.82, suggesting that its stock price is 182% more volatile than the broader market.

Health In Tech has a net margin of 0.00% compared to Health Catalyst's net margin of -90.61%. Health In Tech's return on equity of 0.00% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-90.61%	-1.83%	-0.80%
Health In Tech	N/A	N/A	N/A

85.0% of Health Catalyst shares are owned by institutional investors. 19.4% of Health Catalyst shares are owned by insiders. Comparatively, 77.7% of Health In Tech shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Health In Tech has lower revenue, but higher earnings than Health Catalyst. Health In Tech is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$292.25M	0.41	-$177.97M	-$3.68	N/A
Health In Tech	$32.83M	1.96	-$4.59M	-$0.07	N/A

Summary

Health In Tech beats Health Catalyst on 11 of the 16 factors compared between the two stocks.

How does Health In Tech compare to CareCloud?

Health In Tech (NASDAQ:HIT) and CareCloud (NASDAQ:CCLD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.

Health In Tech has a beta of 2.82, suggesting that its share price is 182% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.51, suggesting that its share price is 51% more volatile than the broader market.

10.2% of CareCloud shares are owned by institutional investors. 77.7% of Health In Tech shares are owned by insiders. Comparatively, 14.8% of CareCloud shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

CareCloud has a net margin of 6.21% compared to Health In Tech's net margin of 0.00%. CareCloud's return on equity of 27.07% beat Health In Tech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
CareCloud	6.21%	27.07%	14.56%

CareCloud has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$32.83M	1.96	-$4.59M	-$0.07	N/A
CareCloud	$120.50M	0.88	$10.80M	$0.07	35.57

In the previous week, Health In Tech and Health In Tech both had 2 articles in the media. Health In Tech's average media sentiment score of 1.12 beat CareCloud's score of 0.96 indicating that Health In Tech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health In Tech	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CareCloud	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Health In Tech presently has a consensus price target of $3.50, indicating a potential upside of 257.14%. CareCloud has a consensus price target of $3.25, indicating a potential upside of 30.52%. Given Health In Tech's stronger consensus rating and higher possible upside, research analysts plainly believe Health In Tech is more favorable than CareCloud.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

CareCloud beats Health In Tech on 8 of the 15 factors compared between the two stocks.

How does Health In Tech compare to Definitive Healthcare?

Health In Tech (NASDAQ:HIT) and Definitive Healthcare (NASDAQ:DH) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment.

Health In Tech has a net margin of 0.00% compared to Definitive Healthcare's net margin of -72.28%. Definitive Healthcare's return on equity of 3.55% beat Health In Tech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Definitive Healthcare	-72.28%	3.55%	1.63%

Health In Tech has higher earnings, but lower revenue than Definitive Healthcare. Health In Tech is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$32.83M	1.96	-$4.59M	-$0.07	N/A
Definitive Healthcare	$241.52M	0.35	-$138.93M	-$1.60	N/A

Health In Tech has a beta of 2.82, indicating that its share price is 182% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.35, indicating that its share price is 35% more volatile than the broader market.

In the previous week, Definitive Healthcare had 1 more articles in the media than Health In Tech. MarketBeat recorded 3 mentions for Definitive Healthcare and 2 mentions for Health In Tech. Health In Tech's average media sentiment score of 1.12 beat Definitive Healthcare's score of 0.83 indicating that Health In Tech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health In Tech	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Definitive Healthcare	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

98.7% of Definitive Healthcare shares are owned by institutional investors. 77.7% of Health In Tech shares are owned by insiders. Comparatively, 17.1% of Definitive Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Health In Tech currently has a consensus target price of $3.50, indicating a potential upside of 257.14%. Definitive Healthcare has a consensus target price of $1.47, indicating a potential upside of 83.38%. Given Health In Tech's stronger consensus rating and higher possible upside, research analysts plainly believe Health In Tech is more favorable than Definitive Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Definitive Healthcare	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.89

Summary

Health In Tech beats Definitive Healthcare on 10 of the 16 factors compared between the two stocks.

Get Health In Tech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HIT vs. The Competition

Export

Metric	Health In Tech	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$64.22M	$1.79B	$7.20B	$12.90B
Dividend Yield	N/A	4.68%	2.54%	11.28%
P/E Ratio	-14.00	21.60	273.16	25.45
Price / Sales	1.96	86.90	592.32	71.88
Price / Cash	N/A	31.93	76.74	53.00
Price / Book	N/A	7.49	12.98	6.14
Net Income	-$4.59M	-$18.66M	$3.48B	$348.86M
7 Day Performance	-2.00%	2.40%	0.13%	-0.80%
1 Month Performance	-5.77%	15.25%	7.08%	4.13%
1 Year Performance	-64.36%	-14.96%	24.67%	15.17%

Health In Tech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HIT Health In Tech	2.6433 of 5 stars	$0.98 -2.0%	$3.50 +257.1%	-64.4%	$64.22M	$32.83M	N/A	79	Positive News
AMWL American Well	2.1361 of 5 stars	$11.84 +0.4%	$9.50 -19.8%	+70.5%	$196.97M	$249.32M	N/A	1,040
OPRX OptimizeRx	4.624 of 5 stars	$7.71 -3.1%	$11.43 +48.2%	-56.0%	$145.23M	$109.43M	33.52	100	Positive News Analyst Upgrade
HCAT Health Catalyst	3.4044 of 5 stars	$1.53 -6.1%	$2.82 +84.5%	-53.1%	$115.14M	$311.14M	N/A	1,200
CCLD CareCloud	4.115 of 5 stars	$2.51 -4.6%	$3.25 +29.5%	-35.2%	$106.66M	$120.50M	35.86	3,650	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HIT) was last updated on 8/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Health In Tech (HIT) Competitors

HIT vs. AMWL, OPRX, HCAT, CCLD, and DH

How does Health In Tech compare to American Well?

Summary

How does Health In Tech compare to OptimizeRx?

Summary

How does Health In Tech compare to Health Catalyst?

Summary

How does Health In Tech compare to CareCloud?

Summary

How does Health In Tech compare to Definitive Healthcare?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIT vs. The Competition

Health In Tech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Health In Tech (HIT) Competitors

HIT vs. AMWL, OPRX, HCAT, CCLD, and DH

How does Health In Tech compare to American Well?

Do insiders & institutionals believe in HIT or AMWL?

Which has higher earnings & valuation, HIT or AMWL?

Does the media prefer HIT or AMWL?

Which has more risk & volatility, HIT or AMWL?

Do analysts rate HIT or AMWL?

Is HIT or AMWL more profitable?

Summary

How does Health In Tech compare to OptimizeRx?

Do insiders & institutionals have more ownership in HIT or OPRX?

Do analysts recommend HIT or OPRX?

Which has more volatility and risk, HIT or OPRX?

Does the media refer more to HIT or OPRX?

Which has preferable earnings & valuation, HIT or OPRX?

Is HIT or OPRX more profitable?

Summary

How does Health In Tech compare to Health Catalyst?

Do analysts rate HCAT or HIT?

Does the media refer more to HCAT or HIT?

Which has more volatility and risk, HCAT or HIT?

Is HCAT or HIT more profitable?

Do insiders and institutionals have more ownership in HCAT or HIT?

Which has stronger earnings and valuation, HCAT or HIT?

Summary

How does Health In Tech compare to CareCloud?

Which has more risk & volatility, HIT or CCLD?

Do institutionals and insiders believe in HIT or CCLD?

Is HIT or CCLD more profitable?

Which has preferable earnings and valuation, HIT or CCLD?

Does the media prefer HIT or CCLD?

Do analysts prefer HIT or CCLD?

Summary

How does Health In Tech compare to Definitive Healthcare?

Is HIT or DH more profitable?

Which has stronger earnings and valuation, HIT or DH?

Which has more risk & volatility, HIT or DH?

Does the media refer more to HIT or DH?

Do insiders and institutionals have more ownership in HIT or DH?

Do analysts prefer HIT or DH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIT vs. The Competition

Health In Tech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools